Meeting
2019 ASCO Annual Meeting
Comparison of risk-reducing surgery in women with BRCA and non-BRCA ovarian cancer susceptibility genes.
Authors
Zachary Phillip Schwartz
Cedars Sinai Medical Center, Los Angeles, CA
Zachary Phillip Schwartz , Mae Zakhour , Andrew John Li , Christine S. Walsh , Bj Rimel , Monica Alvarado , Scott E Lentz , Ilana Cass
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Hereditary Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 37, 2019 (suppl; abstr 1547)
DOI
10.1200/JCO.2019.37.15_suppl.1547
Abstract #
1547
Poster Bd #
41
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
A multicohort phase 2 trial of ADT, docetaxel plus nivolumab in patients with de novo metastatic hormone-sensitive prostate cancer enriched for inflamed tumors and DNA damage repair defects.
First Author: Xiao X. Wei
Poster
2023 ASCO Genitourinary Cancers Symposium
Inherited risk for prostate cancer (PCa): Following the natural history of men with high-risk genetics using multiparametric MRI (mpMRI).
First Author: Anna Couvillon
Poster
2023 ASCO Genitourinary Cancers Symposium
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
First Author: Channing Judith Paller
Poster
2022 ASCO Genitourinary Cancers Symposium
Putative germline findings in tumor-only and liquid biopsy sequencing in veterans with aggressive prostate cancer.
First Author: Kara Noelle Maxwell